Personalized Nutrition During Pregnancy

March 30, 2026 updated by: Olivia Sher

Examining the Effect of Hyper-personalized Nutrition Advice for OBGYN Patients on Health and Wellbeing Outcomes During and After Pregnancy

Dietary quality and total energy intake during pregnancy significantly influences the mother's health during pregnancy and that of the fetus as well as decade long influences on the health outcomes of the child. However, a one size fits all approach to nutritional guidance is far from ideal given the unique biological, lifestyle, demographic, and health condition differences of expecting mothers. This research proposal will examine the effect of precision nutrition on the health and wellbeing outcomes of mothers during pregnancy, at the time of delivery, and post-delivery. Personal nutritional guidance is based on personal biological, behavioral, and health data.

Study Overview

Status

Withdrawn

Conditions

Intervention / Treatment

Detailed Description

Participants will be recruited out of the Maimonides Women's Health Clinic. Each arm will recruit 75 participants. The intervention arm will receive a DNA swab which will be tested and then the patient will receive DNA specific nutrition advice on their smartphone via nine moons app. The other arm will receive no intervention and will only receive standard nutritional advice. Both arms will be followed up every 4 weeks to test vitals and height and weight. Delivery outcomes will be compared at the end of pregnancy.

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • New York
      • Brooklyn, New York, United States, 11220
        • Women's Primary Care Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Pregnant women are less then 20 weeks gestation

Exclusion Criteria:

  • High-risk patients with severe obesity (BMI >35), existing pre-conditions such as diabetes, hypertension, cardiac abnormalities, and need for special medical attention

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Nutrition intervention
Other: Ninemoons app
Individuals in the intervention arm will receive DNA specific nutritional advice on the nine moons app during pregnancy
No Intervention: standard nutrition

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of cesarean section vs. normal vaginal delivery
Time Frame: 9 months
c-section rate
9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Olivia Sher

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 18, 2022

Primary Completion (Actual)

March 15, 2024

Study Completion (Actual)

March 15, 2024

Study Registration Dates

First Submitted

December 6, 2022

First Submitted That Met QC Criteria

March 30, 2026

First Posted (Actual)

April 2, 2026

Study Record Updates

Last Update Posted (Actual)

April 2, 2026

Last Update Submitted That Met QC Criteria

March 30, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2022-03-15

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy Related

Clinical Trials on Ninemoons app

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe